LTFS
IMMU

Ladenburg Thalmann Financial Services’s Immunomedics Inc IMMU Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$65K Buy
3,100
+688
+29% +$12.1K ﹤0.01% 3343
2019
Q3 		$32K Buy
2,412
+498
+26% +$7.32K ﹤0.01% 3744
2019
Q2 		$26K Buy
1,914
+19
+1% +$286 ﹤0.01% 3907
2019
Q1 		$35K Buy
1,895
+1,861
+5,474% +$30K ﹤0.01% 3651
2018
Q4 		$0 Sell
34
-1,966
-98% -$39K ﹤0.01% 5432
2018
Q3 		$42K Sell
2,000
-2,571
-56% -$60.9K ﹤0.01% 3440
2018
Q2 		$67K Hold
4,571
– – ﹤0.01% 3060
2018
Q1 		$67K Buy
4,571
+4,450
+3,678% +$72.7K ﹤0.01% 3060
2017
Q4 		$2K Buy
+121
New +$1.43K ﹤0.01% 4831
2017
Q1 		– Sell
-200
Closed -$1K – 5029
2016
Q4 		$1K Hold
200
– – ﹤0.01% 4761
2016
Q3 		$1K Hold
200
– – ﹤0.01% 4705
2016
Q2 		$0 Buy
+200
New +$668 ﹤0.01% 4891
2015
Q1 		– Sell
-3,000
Closed -$14K – 4698
2014
Q4 		$14K Buy
+3,000
New +$11.9K ﹤0.01% 3224

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return

Ladenburg Thalmann Financial Services's IMMU Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Immunomedics Inc (IMMU) stake by 29% in Q4 2019, buying an estimated $12.1K and bringing the position to 3,100 shares worth $65K. The position accounts for ﹤0.01% of the portfolio, ranked #3343.

Ladenburg Thalmann Financial Services first reported a position in IMMU in Q4 2014 and has held it in 13 quarters since. The position peaked at $67K in Q2 2018. 245 funds tracked by Wall St. Rank hold IMMU as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 3,100 shares of Immunomedics Inc worth $65K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 688 Immunomedics Inc shares in Q4 2019, an estimated $12.1K.
  • Immunomedics Inc made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3343 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Immunomedics Inc in Q4 2014 and has held it in 13 quarters since.
  • Ladenburg Thalmann Financial Services's Immunomedics Inc position peaked at $67K in Q2 2018.
  • 245 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.